Nordic Capital is a leading private equity firm that focuses on investing in high-quality companies in the Nordic region. The firm has a long history of partnering with strong management teams to create value through strategic and operational improvements.

Nordic Capital is a leading private equity investor with a resolute commitment to creating stronger, sustainable businesses through operational improvement and transformative growth. Nordic Capital focuses on selected sectors where it has deep experience and a proven track record. Core sectors are Healthcare, Technology & Payments, Financial Services and in addition, Industrial & Business Services. Key investment regions are Europe and globally for Healthcare and Tech & Payments. Since inception in 1989, Nordic Capital has invested close to EUR 22 billion in over 130 investments. The most recent funds are Nordic Capital Fund XI with EUR 9 billion in committed capital and Nordic Capital Evolution Fund with EUR 1.2 billion in committed capital, principally provided by international institutional investors such as pension funds. The Nordic Capital Funds and vehicles are advised by several advisory entities, which are based in Sweden, Denmark, Finland, Norway, Germany, the UK and the US, any or all of which is referred to as the “Nordic Capital Advisors”. For further information about Nordic Capital, please visit www.nordiccapital.com

iLOQ

Inovalon

Advanz Pharma

Cytel Corporation

Signicat

Nordax Group AB

ProGlove

Duco

Cint

Cloetta

Siteimprove

Trustly

United Veterinary Care

Appium Technologies

Board International

Nordic Capital

COM:NORDICCAPITAL

Nordic Capital

Analysis Not Available